Use of PEG-asparaginase in monomorphic epitheliotropic intestinal T-cell lymphoma, a disease with diagnostic and therapeutic challenges.
We report the use of PEG-asparaginase along with conventional anthracycline therapy in a 70-year-old woman diagnosed with MEITL, who went into remission and survived for more than one year before succumbing to relapsed disease.
PMID: 29062389 [PubMed]
Source: Ecancermedicalscience - Category: Cancer & Oncology Tags: Ecancermedicalscience Source Type: research
More News: Cancer & Oncology | Chemotherapy | Chronic Pain | Diarrhoea | Lymphoma | Pain | Stem Cell Therapy | Stem Cells | T-cell Lymphoma | Transplants | Weight Loss